首页期刊导航|中华血管外科杂志
期刊信息/Journal information
中华血管外科杂志
中华血管外科杂志

季刊

中华血管外科杂志/Journal Chinese Journal of Vascular Surgery
正式出版
收录年代

    脾动脉瘤个体化治疗方式选择及疗效分析的单中心经验

    朱健邱信杰任杰陈电...
    368-372页
    查看更多>>摘要:目的 评价以血管腔内弹簧圈栓塞技术为主的不同方式治疗脾动脉瘤(SAA)的安全性及近中期疗效。 方法 本研究为回顾性队列研究。回顾性分析2018年12月至2022年8月江苏大学医学院附属昆山医院血管外科收治的46例SAA患者的临床资料,其中采用血管腔内弹簧圈栓塞为主的介入治疗29例,急诊开放手术2例,定期随访15例,观察患者围术期并发症及随访结果,评估三种处理方式的安全性及临床疗效。 结果 手术治疗31例患者均获成功。其中29例行腔内SAA弹簧圈栓塞术,手术时间为(48.3±12.6)min,住院时间为(2.3±0.8)d,治疗费用为(6.3±1.1)万元;术后3例出现左季肋部隐痛,1例有低热表现。2例为SAA破裂,急诊行SAA+脾脏切除术,中位手术时间为67.0(54.5,79.5)min,住院时间为7.5(7.3,7.8)d,治疗费用为3.5(3.4,3.5)万元;无术后出血、感染、胰瘘或胰腺炎等严重并发症。随访(13.5±8.0)个月,腔内治疗患者有2例出现小面积脾梗死,其余患者术后无异位栓塞、大面积脾梗死、感染等严重并发症;保守治疗患者15例,复查瘤体均无明显增大。 结论 SAA患者应根据病变解剖位置、大小及进展等进行个体化分析,有手术指征者采用弹簧圈栓塞治疗安全有效,创伤小、并发症少、住院时间短,但费用相对较高。急诊破裂SAA外科手术治疗相对可靠,而无外科干预指征者则可以考虑动态随访。 Objective To evaluate the safety and early- to mid-term efficacy of different modalities for treating splenic artery aneurysm (SAA) mainly by endovascular spring coil embolization technique. Methods This study was a retrospective cohort study. The clinical data of 46 patients with SAA admitted to Department of Vascular Surgery, Kunshan Hospital Affiliated to Jiangsu University School of Medicine from December 2018 to August 2022 were retrospectively analyzed, of which 29 cases were treated with interventional therapy, mainly using endovascular spring coil embolization, 2 cases with emergency open surgery, and 15 cases with regular follow-up. The perioperative complications of the patients and the results of the follow-ups were observed, and the safety and clinical efficacy of the three treatment modalities were evaluated. Results Surgical treatment was successful in 31 patients. Among them, 29 cases underwent spring-coil embolization, with a operation time of (48.3±12.6)min, hospitalization time of (2.3±0.8)d, and treatment cost of (63±11) thousand yuan. Postoperatively, 3 patients developed vague pain in the left quarter rib, and 1 patient showed low fever. Two cases with SAA rupture underwent SAA+splenectomy in the emergency, with a median operation time of 67.0(54.5,79.5)min, hospitalization time of 7.5(7.3,7.8) days, and treatment cost of 35(34,35) thousand yuan. No postoperative serious complications such as hemorrhage, infection, pancreatic fistula, and pancreatitis. At the follow-up of (13.5±8.0) months, 2 patients with endovascular treatment developed small splenic infarction, and the rest of the patients had no severe complications such as heterotopic embolism, large splenic infarction and infection, and 15 patients with conservative treatment had no noticeable enlargement of the tumor in the review. Conclusion Patients with SAA should be examined individually according to the anatomical location, size, and progression of the lesion, and those with surgical indications should be treated with spring coil embolization, which is safe and effective, with less trauma, fewer complications, and shorter hospital stay, but with relatively high cost. Surgical treatment of emergent ruptured SAA is relatively reliable, while dynamic follow-up may be considered for those without indication for surgical intervention.

    脾动脉瘤弹簧圈栓塞腔内治疗

    Castor分支支架联合原位开窗技术治疗主动脉弓部疾病的近期疗效观察

    龚勇泉卢天成农巍吴先球...
    373-376页
    查看更多>>摘要:目的 总结分析Castor分支支架联合开窗技术治疗主动脉弓部疾病的近期临床效果。 方法 本研究为回顾性纵向研究。回顾性分析2022 年3月至2023年2月柳州市人民医院心脏血管外科15例采用Castor支架联合开窗技术治疗主动脉弓部疾病患者的资料,其中弓部动脉瘤10例,主动脉溃疡5例。Castor主体支架锚定在Z1区,分支支架植入左颈总动脉,左锁骨下动脉原位开窗。观察围术期和随访期情况。 结果 本组患者技术成功率100%,手术时间(127.0±9.8)min,住院时间(14±2)d,围术期未发现明显内漏及其他严重并发症。15例患者均获得随访,随访时间为(6.2±4.2)个月。随访期内,未见支架移位,主体支架、分支支架以及开窗支架通畅良好,无内漏发生,无中枢神经系统并发症。 结论 Castor支架联合左锁骨下动脉原位开窗技术处理主动脉弓部疾病近期临床效果良好。 Objective To investigate the short-term effect of in situ needle fenestration (ISNF) with Castor single-branched stent graft for aortic arch diseases. Methods This study was a retrospective longitudinal study. Fifteen cases of aortic arch disease, from March 2022 to February 2023 in Liuzhou People's Hospital, treated by ISNF with Castor single-branched stent graft were retrospectively analyzed. Among them, there were 10 cases of aortic arch aneurysm and 5 cases of penetrating aortic ulcer. The main stent was anchored in the Z1 zone while the branched stent were implanted into the left carotid artery. Accordingly, the left subclavian artery was reconstructed using ISNF. General conditions during perioperative and follow-up periods were observed. Results Full technical success was achieved among all the patients. The operation time was (127.0±9.8) min. The hospital stay was (14±2) days. No endoleaks or other severe complications were found after operation. All the patients were followed up for (6.2±4.2) months, during which all the stents were in good position with excellent patency of the main stent, branched stent and fenestrated stent. No endoleaks or central nervous system complications were found. Conclusion Castor single-branched stent graft combined with ISNF has satisfactory short-term clinical efficacy for treating aortic arch diseases.

    主动脉疾病分支支架原位开窗腔内修复

    应用常规器械行经皮腔内股腘动脉旁路术一例

    钱宇轩鲁城然谭树平许政曦...
    377-379页
    查看更多>>摘要:本文报告一例采用常规器械完成经皮腔内股腘动脉旁路术治疗右下肢股腘动脉长段闭塞的病例,术后患肢的血运明显改善,手术效果良好。

    股腘动脉闭塞下肢动脉长段闭塞经皮腔内股腘动脉旁路术

    下肢浅静脉功能不全治疗技术的研究进展

    毛贻静许晓婕吴侃王丽萍...
    380-384页
    查看更多>>摘要:下肢静脉曲张是血管外科的常见病之一,外科治疗方式有大隐静脉高位结扎及剥脱术、腔内热消融治疗、常温闭合治疗及高强度聚焦超声治疗等。各治疗技术均有其优缺点,本文将对目前较常用的一些技术进行阐述,为该疾病的个体化治疗提供思路。 Varicose veins of lower extremities are one of the most common diseases in vascular surgery. Surgical treatments for it include high ligation and stripping of the great saphenous vein, endovascular thermal ablation, normal temperature closure and high-intensity focused ultrasound, etc. Each treatment technique has its advantages and disadvantages. This article will elaborate some techniques commonly used, providing ideas for personalized treatment of this disease.

    下肢静脉曲张腔内热消融治疗常温闭合治疗

    动脉粥样硬化细胞免疫机制及其靶向治疗的研究进展

    张时婕曾赞周建王丽萍...
    385-388页
    查看更多>>摘要:动脉粥样硬化(AS)是一种慢性炎症性血管疾病。随着我国经济发展及生活水平的提高,AS患者年轻化,已成为严重危害我国人民健康和生活质量的疾病之一。免疫细胞在AS的发生发展中起着关键作用,因此免疫细胞靶向治疗AS是一种有前景的治疗策略。本文总结了T细胞、B细胞、巨噬细胞、树突细胞及中性粒细胞在AS发生发展中的作用并针对免疫细胞靶向治疗AS的策略进行了综述。 Atherosclerosis (AS) is a chronic inflammatory vascular disease. With the development of economy and the improvement of living standards in our country, AS patients with young people have become one of the diseases seriously endangering people's health and quality of life in our country. Immune cells play a key role in the occurrence and development of AS, so the targeted treatment of immune cells for AS is a promising therapeutic strategy. This review summarize the role of T cells, B cells, macrophages, dendritic cells and neutrophils in the occurrence and development of AS, and review the strategies for the targeted treatment of AS by immune cells

    动脉粥样硬化炎症免疫细胞靶向治疗